Agenovir’s mission is to develop innovative antiviral therapeutics that will improve clinical outcomes of patients with diseases caused by latent or persistent viral reservoirs. Agenovir’s core technology platform, originally from the laboratory of Dr. Stephen Quake of Stanford University, harnesses novel nucleases such as CRISPR/Cas9 for the treatment of disease. We seek talented and enthusiastic employees who possess an entrepreneurial and collaborative spirit and embrace our mission. Contact us to learn more about job opportunities.

Current Openings
Fill out my online form.
Contact Us

7000 Shoreline Court, Suite 320
South San Francisco, CA 94080

Telephone: (650) 287-3300